Fundraising FoxBaebies
Research Triangle Park, US · Delaware corporation · 8 known investors
Find your way into Baebies
Sign up to see every warm intro you have to Baebies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Baebies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples. Its products serve hospitals, clinics, pharmacies, and decentralized care settings for patients of all ages, having started with newborn and pediatric diagnostics.
Founders & leadership
VP
Vamsee PamulaFounder and President, Board of DirectorsVamsee Pamula holds an engineering degree and has experience spanning research, product development, and business operations, including work on diagnostic technologies and startup scaling from concept through commercialization.
Board
DS
Dennis SachaBoard director
WA
William A. HawkinsBoard director
Investors · 8
Charlotte Angel Fundlisted by Charlotte Angel FundCharlotte
How we know: Charlotte Angel Fund's portfolio page · Not right? Tell us
IAG Capital Partnerslisted by IAG Capital PartnersCharlestonvia Joel Whitley · inferred
How we know: IAG Capital Partners's portfolio page · Not right? Tell us
Rex Health Ventureslisted by Rex Health VenturesRaleigh · $250K – $500K
How we know: Rex Health Ventures's portfolio page · Not right? Tell us
Solas BioVentureslisted by Solas BioVenturesChattanooga
How we know: Solas BioVentures's portfolio page · Not right? Tell us
VentureSouthlisted by VentureSouthGreenville
How we know: VentureSouth's portfolio page · Not right? Tell us
HG VenturesreportedIndianapolis · $1M – $10M
How we know: a partner's Signal profile · Not right? Tell us
Johnson & Johnson Innovation – JJDCreportedNew Brunswick
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$92.8M disclosed across 5 rounds · 2013–2025
▶$2MraisedSep 2025 · 24 investors · Other Health CareRule 506(b)
▶$2MraisedSep 2025 · 24 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dennis SachaDirector
- Vamsee PamulaExecutive Officer, Director
- Richard M. WestExecutive Officer, Director
- William A. HawkinsDirector
- Offering amount
- $10M
- Amount sold
- $2M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$37.6MraisedMay 2022 · 87 investors · Other Health CareRule 506(b)
▶$37.6MraisedMay 2022 · 87 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard M WestExecutive Officer, Director
- William A HawkinsDirector
- Nicholas NaclerioDirector
- Vamsee PamulaExecutive Officer, Director
- Dennis SachaDirector
- Offering amount
- $50M
- Amount sold
- $37.6M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.9MraisedFeb 2022 · 87 investors · Other Health CareRule 506(b)
▶$11.9MraisedFeb 2022 · 87 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard M WestExecutive Officer, Director
- Dennis SachaDirector
- William A. HawkinsDirector
- Nicholas NaclerioDirector
- Vamsee PamulaExecutive Officer, Director
- Offering amount
- $11.9M
- Amount sold
- $11.9M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$28.3MraisedMay 2021 · 173 investors · Other Health CareRule 506(b)
▶$28.3MraisedMay 2021 · 173 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard M WestExecutive Officer, Director
- Vamsee PamulaExecutive Officer, Director
- Nicholas NaclerioDirector
- William A. HawkinsDirector
- Lucy MartindaleExecutive Officer
- Offering amount
- $28.5M
- Amount sold
- $28.3M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13MraisedAug 2015 · 94 investors · Other Health CareRule 506(b)
▶$13MraisedAug 2015 · 94 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard M. WestExecutive Officer, Director
- Vamsee PamulaExecutive Officer, Director
- Offering amount
- $13M
- Amount sold
- $13M
- First sale
- Aug 2013
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Baebies.
Non-dilutive funding · 37 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $830.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $266.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $2.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $278.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $467.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $215.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $246.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $232.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $231.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $215.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $215K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $272.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $254.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Baebies do?
- Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples. Its products serve hospitals, clinics, pharmacies, and decentralized care settings for patients of all ages, having started with newborn and pediatric diagnostics.
- Who founded Baebies?
- Baebies was founded by Vamsee Pamula.
- Who are Baebies's investors?
- Baebies's investors include Charlotte Angel Fund, Duke Capital Partners, IAG Capital Partners, Rex Health Ventures, Solas BioVentures, VentureSouth, HG Ventures, Johnson & Johnson Innovation – JJDC.
- How much funding has Baebies raised?
- Baebies has disclosed $92.8M raised across 5 rounds.
- Where is Baebies headquartered?
- Baebies is headquartered in Research Triangle Park, US.